|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2024―Dez―07 |
Corrigendum to ‘Inflammatory pathways in patients with post-acute sequelae of COVID-19’ [Annals of Allergy, Asthma & Immunology 133/5 (2024) 507 - 515] |
Matthew R. Elliott, Anna E. O'Connor, Gailen D. Marshall |
2 |
[GO] |
2024―Nov―01 |
Post-pandemic, long COVID persists |
Donald Y.M. Leung |
3 |
[GO] |
2024―Okt―25 |
A CASE OF SYSTEMIC CAPILLARY LEAK SYNDROME (SCLS) IN THE SETTING OF COVID-19 |
P. Retnakumar, B. Navetta-Modrov |
4 |
[GO] |
2024―Okt―25 |
ASSOCIATION OF COMORBID ASTHMA TO IN-HOSPITAL OUTCOMES IN PATIENTS HOSPITALIZED FOR COVID-19 INFECTION |
A. Siwakoti, S. Khadka, M. Uprety, S. Giri |
5 |
[GO] |
2024―Okt―25 |
IMPACT OF SARS-COVID 19 INFECTION ON IMMUNE PARAMETERS OF UROLITHIASIS PATIENTS |
T. Poroshina, V. Driianska, O. Vozianov, V. Savchuk, D. Chernenko, L. DuBuske |
6 |
[GO] |
2024―Okt―25 |
EMERGENCY DEPARTMENT VISITS FOR PEDIATRIC FOOD ALLERGIES DURING THE COVID 19 PANDEMIC |
J. Devera, C. Esteban, G. Cushman, S. Chandra, M. Scarpaci, T. Zheng, et al. (+2) D. Barker, E. McQuaid |
7 |
[GO] |
2024―Okt―25 |
STRATIFYING RISK FOR LONG COVID IN PATIENTS WITH IMMUNODEFICIENCY |
M. Aglan, K. Gilbert, M. Ong, J. Farmer |
8 |
[GO] |
2024―Aug―23 |
“Inflammatory Pathways in Patients with Post-acute Sequelae of COVID-19 - The Role of the Clinical Immunologist” |
Matthew R. Elliott, Anna E. O'Connor, Gailen D. Marshall |
9 |
[GO] |
2024―Aug―09 |
Long COVID in pediatric patients with chronic health issues: How to assess and support. |
Joy Goldberg, Nathan Rabinovitch, Bruce Bender |
10 |
[GO] |
2024―Jan―21 |
Association between allergic conditions and COVID-19 susceptibility and outcomes |
Chao Chen, Xue Song, Dana J. Murdock, Andrea Marcus, Mohamed Hussein, Jessica J. Jalbert, Gregory P. Geba |
11 |
[GO] |
2024―Jan―18 |
The Impact of Coronavirus Disease 2019 (COVID-19) Vaccine Reactions on Secondary Vaccine Hesitancy |
Esther E. Freeman, Alexis G. Strahan, Liam R. Smith, Allen D. Judd, Upeka Samarakoon, Geoffrey Chen, et al. (+2) Andrew J. King, Kimberly G. Blumenthal |
12 |
[GO] |
2023―Dez―03 |
Case series of patients with acute and chronic urticaria after COVID-19 vaccination |
Andrew Nickels, Supriya Varadarajulu, Pamela Harris, Alexandra Graden, Annely Richardson, Trisha Saha, et al. (+3) Elyse O Kharbanda, Jingyi Zhu, Gabriela Vazquez-Benitez |
13 |
[GO] |
2023―Nov―09 |
AGE, SEX, OBESITY, AND CONTROLLER THERAPY MODERATE THE RELATIONSHIP BETWEEN PEDIATRIC ASTHMA EXACERBATIONS AND COVID-19 |
J. Barrows, S. Galant, T. Morphew |
14 |
[GO] |
2023―Nov―09 |
ASSESSING SEVERITY OF COVID-19 AND THE DEVELOPMENT OF MIS-C IN PEDIATRIC PATIENTS WITH ATOPIC DISEASE |
N. Rudsenske, J. Perkins |
15 |
[GO] |
2023―Nov―09 |
INCIDENCE AND PREDICTORS OF CUTANEOUS REACTIONS TO THE COVID-19 BOOSTER VACCINE |
R. Shah, A. King, E. Shenoy, A. Landman, D. Hashimoto, K. Blumenthal |
16 |
[GO] |
2023―Nov―09 |
PROTEIN LOSING ENTEROPATHY, HYPOALBUMINEMIA, HYPOGAMMAGLOBULINEMIA AND ANASARCA ASSOCIATED WITH RECURRENT COVID-19 INFECTION |
C. Gunderson, C. Chang, N. Hamburger |
17 |
[GO] |
2023―Nov―09 |
UNDEFINED AUTOINFLAMMATORY CONDITION FOLLOWING COVID-19 INFECTION |
O. Humpel, L. Nagireddi, R. Hostoffer |
18 |
[GO] |
2023―Nov―09 |
FROM SEVERE COVID-19 INFECTION TO GENETIC REVELATION: TOLL-LIKE RECEPTOR 7 DEFICIENCY IN TWO BROTHERS |
B. Schornack, M. Leondaridis, J. McMurray, N. Boggs, A. Snow |
19 |
[GO] |
2023―Nov―09 |
GRAFT-VERSUS-HOST-DISEASE - A RARE COVID-19 MRNA VACCINE SIDE EFFECT IN POST STEM CELL TRANSPLANT PATIENTS |
K. Sese |
20 |
[GO] |
2023―Nov―09 |
THE EFFECT OF COVID-19 ON PEDIATRIC ASTHMA ICU ADMISSIONS AT A SINGLE CENTER. |
P. Le |
21 |
[GO] |
2023―Nov―09 |
ALLERGY IMMUNOLOGY FELLOWSHIP EDUCATION DURING COVID-19 PANDEMIC |
A. Yeich, M. Matheny, N. Maglakelidze, L. Mazur, T. Craig |
22 |
[GO] |
2023―Nov―09 |
SARS-COV2 SPECIFIC ANTIBODY RESPONSES TO COVID-19 VACCINATION IN COMMON VARIABLE IMMUNODEFICIENCY |
K. Zhang, S. Agrawal, S. Gupta |
23 |
[GO] |
2023―Nov―09 |
AUTOIMMUNE RESPONSE TO THE COVID-19 VACCINE ELICITING VITILIGO |
A. Mittman |
24 |
[GO] |
2023―Nov―09 |
DOUBLE BLIND RANDOMIZED CONTROLLED TRIAL OF SALINE SOLUTION GARGLING AND NASAL RINSING IN SARS-COV-2 INFECTION |
S. Espinoza, L. Trauffler, A. Shamshirsaz, A. Shamshirsaz, A. Espinoza, J. Espinoza, A. O'Brien |
25 |
[GO] |
2023―Nov―09 |
EFFECT OF THE SARS-COV-2 PANDEMIC ON PEDIATRIC ASTHMA HEALTH-CARE UTILIZATION IN AN URBAN TERTIARY-CARE HOSPITAL |
H. Zomer Bolanos, M. Reznik, E. Rothschild, L. Conrad, M. Cabana |
26 |
[GO] |
2023―Nov―09 |
CD14 (C-159)T GENE POLYMORPHISM IN SARS-COV-2 PATIENTS IN CRIMEA |
V. Beloglazov, I. Yatskov, L. Dudchenko, E. Ageeva, L. DuBuske |
27 |
[GO] |
2023―Nov―09 |
THE NOISE ABOUT SARS-COV-2 VACCINATION: A RETROSPECTIVE COHORT STUDY EVALUATING TINNITUS AND VACCINATION |
J. Pollock, D. Hoffman, A. Tolisano, L. Housel, R. Lee |
28 |
[GO] |
2023―Nov―09 |
FREQUENCY OF T-330G IL-2 GENE SNP IN SARS-COVID-19 PATIENTS |
V. Beloglazov, I. Yatskov, E. Ageeva, L. DuBuske |
29 |
[GO] |
2023―Aug―23 |
Population-Level Trends in Asthma and COPD Emergency Department Visits and Hospitalizations Before and During the COVID-19 Pandemic in the US |
Adam Gaffney, David U. Himmelstein, Steffie Woolhandler |
30 |
[GO] |
2023―Aug―07 |
Asthma in elderly and COVID-19: results of 90-day post-hospital follow-up |
Sergey N. Avdeev, Viliya V. Gaynitdinova, Anna A. Pozdnakova, Svetlana Yu Chikina, Karina A. Kosobokova |
31 |
[GO] |
2023―Aug―01 |
Did the coronavirus disease 2019 pandemic change asthma prevalence? |
Rebecca Koenigsberg, Mitchell H. Grayson |
32 |
[GO] |
2023―Jul―05 |
Intranasal steroid use and COVID-19 mortality among asthma and COPD patients: A retrospective cohort study |
Dr Virginia Hernandez Santiago, Dr Adeniyi Francis Fagbamigbe, Prof Frank Sullivan, Dr Utkarsh Agrawal, Dr Daniel Morales, Prof Colin McCowan, Prof Brian Lipworth |
33 |
[GO] |
2023―Jun―15 |
Controller therapy attenuates asthma exacerbations associated with prior SARS-CoV-2 infection in children |
Iris Kim, Tricia Morphew, Christine Chou, Louis Ehwerhemuepha, Stanley Galant |
34 |
[GO] |
2023―Mai―03 |
Changes in the national prevalence of asthma and COVID-19 fatality: A population-based cross-sectional study |
Martín Bedolla-Barajas, Jaime Morales-Romero, Martín Robles-Figueroa, Tonatiuh Delgado-Figueroa |
35 |
[GO] |
2023―Apr―19 |
Asthma medication adherence during the COVID-19 pandemic in children at high risk of exacerbation |
Colleen M Shannon, Carina Flaherty, William O Quarshie, Rui Xiao, Chén C Kenyon |
36 |
[GO] |
2023―Apr―07 |
COVID-19 vaccine skin testing and graded challenges in vaccine hesitant patients |
Ari Heffes-Doon, Nathanael Horne, Chinyere Okpara, Meredith Akerman, Luz Fonacier |
37 |
[GO] |
2023―Mrz―15 |
The Role of IL-13 and the Type 2 Immune Pathway in COVID-19: A Review |
Jennifer Sasson, G. Brett Moreau, William A. Petri |
38 |
[GO] |
2023―Feb―02 |
Antibody and T-cell responses to COVID-19 Vaccination in Common Variable Immunodeficiency and Specific Antibody Deficiency |
Jamie A. Rosenthal, Michelle Premazzi Papa, Marta Sanz, Samuel Nicholes, Carissa Stower, Alberto Bosque, et al. (+5) Anjeni Keswani, Richard Amdur, Rebecca M. Lynch, Natalia Soriano-Sarabia, Daniel Ein |
39 |
[GO] |
2022―Dez―10 |
Impact of Vaccination against SARS-CoV-2 on the Atopic Dermatitis Serum Proteome |
Madeline Kim, Benjamin Ungar, Yeriel Estrada, Ana B. Pavel, Emma Guttman-Yassky |
40 |
[GO] |
2022―Dez―01 |
Is there value in coronavirus disease 2019 vaccine and vaccine excipient skin testing or split dosing? |
Matthew Greenhawt |
41 |
[GO] |
2022―Dez―01 |
Split-dosing of coronavirus disease 2019 vaccines |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
42 |
[GO] |
2022―Nov―10 |
DETERIORATION OF RESPIRATORY STATUS IN A CVID PATIENT WITH GLILD AND COVID-19 |
N. Kimura, A. Jongco |
43 |
[GO] |
2022―Nov―10 |
A CASE SERIES: CHRONIC INDUCIBLE URTICARIA FOLLOWING COVID-19 INFECTION AND MRNA VACCINE |
T. Hellu, S. Weiss, K. Adams |
44 |
[GO] |
2022―Nov―10 |
A CASE OF PULMONARY EMBOLISM POST COVID-19 INFECTION IN A PATIENT WITH STAT3 MUTATION |
H. Blunk, K. Birch, M. Callahan, R. Hostoffer |
45 |
[GO] |
2022―Nov―10 |
THE IMPORTANCE OF B CELLS IN OVERCOMING COVID-19 INFECTION IN COMMON VARIABLE IMMUNODEFICIENCY PATIENTS. |
J. Brozyna, H. Li, A. Hassoun, F. Ibrahim |
46 |
[GO] |
2022―Nov―10 |
INCIDENCE OF COVID-19 INFECTIONS IN ADULTS WITH PRIMARY IMMUNODEFICIENCY AFTER RECEIVING TIXAGEVIMAB AND CILGAVIMAB |
S. Johnson, J. Fernandez |
47 |
[GO] |
2022―Nov―10 |
OUTCOMES AND IMPACT OF COVID-19 ON INFECTION DIAGNOSIS RATES AMONG PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES |
F. Riaz, K. Umashankar, E. Marchlewicz, K. Zhang, M. Sanchirico |
48 |
[GO] |
2022―Nov―10 |
LIKELIHOOD OF DIAGNOSIS OF EOSINOPHILIC ESOPHAGITIS VIA ENDOSCOPY IN DYSPHAGIA DURING THE COVID-19 PANDEMIC |
J. Brennan, K. Yamada, T. Al-Shaikhly, G. Ghaffari |
49 |
[GO] |
2022―Nov―10 |
THE IMPACT OF COVID-19 PANDEMIC ISOLATION MEASURES ON PEDIATRIC ASTHMA ADMISSIONS |
S. Raja, V. Nguyen, R. Heinle, J. Hossain |
50 |
[GO] |
2022―Nov―10 |
BIOMARKERS OF CYTOKINE STORM AND INFLAMMATION IN SEPSIS, POST-COVID-19 PATIENTS AND COVID-19 VACCINATED INDIVIDUALS |
L. Titov, M. Trusevich, T. Amvrosieva, I. Belskaya, Y. Gorbich, L. DuBuske |
51 |
[GO] |
2022―Nov―10 |
POLYMYALGIA RHEUMATICA AFTER MRNA COVID-19 VACCINATION |
N. Trotto, S. Hauk, S. Fowler, B. McGoey, J. Ravell |
52 |
[GO] |
2022―Nov―10 |
SECONDARY URTICARIAL VASCULITIS AND CHRONIC SPONTANEOUS URTICARIA ASSOCIATED WITH COVID-19 VACCINATION |
T. Chang, F. Tachibana, V. Wang, J. Yusin |
53 |
[GO] |
2022―Nov―10 |
PRE-VACCINE COUNSELING TO ASSIST WITH RISK ASSESSMENT PRIOR TO COVID-19 VACCINATION |
J. Rosenblum, C. Yie, M. Akerman, E. Banta |
54 |
[GO] |
2022―Nov―10 |
PERSISTENT ANGIOEDEMA AFTER COVID-19 VACCINATION: IS BRADYKININ TO BLAME? |
G. Edland, S. Awan, A. James, A. Keswani |
55 |
[GO] |
2022―Nov―10 |
COVID-19 VACCINE ADMINISTRATION IN PATIENTS WITH FIRST-DOSE ADVERSE REACTIONS OR HISTORY OF SEVERE ALLERGIC REACTION |
K. Vanijcharoenkarn, F. Lee, M. Kalangara |
56 |
[GO] |
2022―Nov―10 |
COVID-19 VACCINE REACTIONS AND SUSPECTED POLYETHYLENE GLYCOL ALLERGY: A PEDIATRIC CASE SERIES |
M. Laditan, A. Martone, D. Doshi |
57 |
[GO] |
2022―Nov―10 |
REDUCED COVID-19 VACCINE RESPONSE IN PATIENT TREATED WITH DUPILUMAB FOR IGG4 RELATED DISEASE. |
A. Abadeh, J. Lee |
58 |
[GO] |
2022―Nov―10 |
MRNA COVID-19 VACCINE-ASSOCIATED BULLOUS FIXED DRUG ERUPTION |
S. Imam, T. Carpenter, A. Wolff, R. Khianey, E. Capitle |
59 |
[GO] |
2022―Nov―10 |
RISK OF ANAPHYLAXIS TO THE COMPONENTS OF THE COVID-19 VACCINE: A STUDY IN MEXICAN POPULATION |
R. Lopez Henriquez, J. Uc Rosado, S. Gonzalez-Diaz, R. Villarreal Gonzalez, C. De Lira-Quezada, A. Macias-Weinmann, et al. (+2) C. Macouzet-Sanchez, T. Delgado Guzmán |
60 |
[GO] |
2022―Nov―10 |
REVISITING HYPERSENSITIVITY REACTIONS TO THE MRNA COVID-19 VACCINE: TOLERANCE AFTER PREVIOUS HISTORY OF ANAPHYLAXIS |
I. AlOtaibi, F. ALMuhizi, S. Ton-Leclerc, M. Fein, M. Ben-Shoshan, G. Isabwe, A. Copaescu |
61 |
[GO] |
2022―Nov―10 |
SPLIT-DOSING OF COVID-19 VACCINES IS SAFE AND PROVIDES NON-INFERIOR ANTIBODY RESPONSIVENESS TO CONVENTIONAL VACCINE DOSING |
A. Musa, M. Wood, S. May, A. Rorie, J. Van De Graaff, R. Walenz, et al. (+2) P. Fey, J. Poole |
62 |
[GO] |
2022―Nov―10 |
IMMUNIZATION STRESS-RELATED RESPONSES DURING SKIN TESTING AND CHALLENGE TO COVID-19 VACCINES: A CASE SERIES |
H. Jin, L. Fonacier |
63 |
[GO] |
2022―Nov―10 |
TOLERABILITY OF GRADED CORONAVIRUS DISEASE 2019 MRNA VACCINE DOSING |
B. Hamel, M. Pitlick, A. Joshi |
64 |
[GO] |
2022―Nov―10 |
BRACHIAL NEURITIS FROM THE MRNA SARS-COV-2 AND INFLUENZA VACCINES |
J. VanLancker, D. Sheth |
65 |
[GO] |
2022―Nov―10 |
SARS-COV-2 ANTIBODY LEVELS CONTINUE TO RISE IN IMMUNE GLOBULIN PREPARATIONS |
Q. Wang, H. Park |
66 |
[GO] |
2022―Nov―10 |
SARS-COV-2 INFECTION ASSOCIATED WITH NEW SEVERE HYPEREOSINOPHILIA AND MULTIPLE ORGAN DAMAGE |
J. Eremija, N. Odisho Domit, T. Carr |
67 |
[GO] |
2022―Nov―10 |
RESISTANCE TO GLUCOCORTICOSTEROID THERAPY IN PATIENTS WITH SARS-COV-2 INFECTION WITH ELEVATED MARKERS OF ENDOTOXEMIA |
V. Beloglazov, I. Yatskov, L. DuBuske |
68 |
[GO] |
2022―Nov―01 |
The intersection of the sunshine act, sutton's law, and the pandemic |
Marcus Shaker |
69 |
[GO] |
2022―Okt―22 |
COVID-19 patients are characterized by dysregulated levels of membrane and soluble CD48 |
Hadas Pahima, Ilan Zaffran, Eli Ben-Chetrit, Amir Jarjoui, Pratibha Gaur, Maria Laura Manca, et al. (+7) Dana Reichmann, Efrat Orenbuch-Harroch, Ekaterini Tiligada, Ilaria Puxeddu, Carl Zinner, Alexandar Tzankov, Francesca Levi-Schaffer |
70 |
[GO] |
2022―Okt―12 |
Enhanced SARS-CoV-2 IgG durability following COVID-19 mRNA booster vaccination and comparison of BNT162b2 with mRNA-1273 |
Samuel M. Ailsworth, Behnam Keshavarz, Nathan E. Richards, Lisa J. Workman, Deborah D. Murphy, Michael R. Nelson, et al. (+2) Thomas A.E. Platts-Mills, Jeffrey M. Wilson |
71 |
[GO] |
2022―Sep―07 |
Split-Dosing of COVID-19 Vaccines Provides Non-Inferior Antibody Responsiveness to Conventional Vaccine Dosing |
Amal Musa, Macy Wood, Andrew Rorie, Sara M. May, Joel Van De Graaff, Jill A. Poole |
72 |
[GO] |
2022―Aug―18 |
Antibody response to coronavirus disease 2019 vaccines after allergic reaction to first dose |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
73 |
[GO] |
2022―Aug―13 |
Industry Payments to Allergists and Clinical Immunologists in the United States during the COVID-19 pandemic |
Anju Murayama, Sae Kamamoto, Hiroaki Saito, Tetsuya Tanimoto, Akihiko Ozaki |
74 |
[GO] |
2022―Jul―30 |
Anxiety in Adults with Allergic Rhinitis During the Coronavirus Disease 2019 Pandemic: A Canadian Perspective |
Kayley Xu, Sophia Linton, Adam Sunavsky, Sarah Garvey, Hannah Botting, Lisa M Steacy, et al. (+3) Wilma M Hopman, Dean A Tripp, Anne K Ellis |
75 |
[GO] |
2022―Jul―23 |
Causation or coincidence? Phenotype of asthma exacerbations during the coronavirus disease 2019 pandemic |
Christian Coletta, Mitchell H. Grayson |
76 |
[GO] |
2022―Jul―23 |
Lessons from the IMPAACT of coronavirus disease 2019 public health restrictions on food allergy-associated anxiety |
Michael A. Golding, Jennifer L.P. Protudjer |
77 |
[GO] |
2022―Jul―17 |
Patch Testing Results in Adult Patients with Dermatitis during the COVID-19 Pandemic |
Stephanie Kong, Stephanie L Mawhirt |
78 |
[GO] |
2022―Jun―16 |
Immunizing the Imperfect Immune System: COVID-19 Vaccination in Patients with Inborn Errors of Immunity |
Jessica R. Durkee-Shock, Michael D. Keller |
79 |
[GO] |
2022―Mai―28 |
Predictors of seroconversion following COVID-19 vaccination |
Sergio E. Chiarella, Sarah M. Jenkins, Carin Y. Smith, Vikas Prasad, Fnu Shakuntulla, Vaibhav Ahluwalia, et al. (+3) Vivek N. Iyer, Elitza S. Theel, Avni Y. Joshi |
80 |
[GO] |
2022―Mai―21 |
Allergic Reactions to the COVID-19 vaccine (ARCOV) study: the McGill University Health Center (MUHC) experience |
Faisal ALMuhizi, Michael Fein, Sofianne Gabrielli, Louise Gilbert, Christos Tsoukas, Moshe Ben-Shoshan, et al. (+2) Ana M. Copaescu, Ghislaine A.C Isabwe |
81 |
[GO] |
2022―Mai―20 |
A case of coronavirus disease 2019 messenger RNA vaccine tolerance and immune response despite presence of anti-polyethylene glycol antibodies |
Kristen B. Corey, Grace Koo, Cosby A. Stone, Susan F. Kroop, William H. Fissell, Steven Kozlowski, et al. (+2) Zhao-Hua Zhou, Elizabeth J. Phillips |
82 |
[GO] |
2022―Mai―20 |
The Role of the Allergist in Coronavirus Disease 2019 Vaccine Allergy Safety |
Valerie Chiang, Chinmoy Saha, Jackie Yim, Elaine Y.L. Au, Andy K.C. Kan, Kong Siu Harris Hui, et al. (+10) Tin Sum Li, Wing Lam Whitney Lo, Yuh Dong Hong, Jiaxi Ye, Carmen Ng, Welchie W.K. Ko, Carmen T.K. Ho, Chak Sing Lau, Jianchao Quan, Philip H. Li |
83 |
[GO] |
2022―Mai―19 |
Outcomes of Allergic Type Reactions Following mRNA COVID-19 Vaccination at Three Military Medical Centers |
Benjamin D. St Clair, Donna L. Hoffman, Bruce McClenathan, Taylor Banks, Rachel U. Lee |
84 |
[GO] |
2022―Mai―17 |
Antibody Response to Graded Dosing of COVID-19 mRNA Vaccines After Allergic Reaction to First Dose |
Sara W Van Meerbeke, Merritt L Fajt, Rachel V Marini, Robyn T Domsic, Andrej A Petrov |
85 |
[GO] |
2022―Apr―23 |
COVID-19 Related Anxiety Is Associated with Uncontrolled Asthma in Adults |
Kamal M Eldeirawi, Sharmilee M. Nyenhuis, Luz Huntington-Moskos, Barbara J. Polivka |
86 |
[GO] |
2022―Apr―23 |
Decreased food-allergy-specific anxiety and increased general anxiety in parents of children with food allergies during COVID-19 |
Clara Westwell-Roper, Sharon To, Lianne Soller, Edmond S. Chan, S. Evelyn Stewart |
87 |
[GO] |
2022―Apr―08 |
Effect of the COVID-19 pandemic on morbidity among children hospitalized for an asthma exacerbation |
Nada Alabdulkarim, Jiaxiang Gai, James Bost, Dinesh Pillai, Stephen J. Teach, Deepa Rastogi |
88 |
[GO] |
2022―Apr―06 |
Specific antibody response of 14 common variable immunodeficiency patients to three BNT162b2 mRNA COVID-19 vaccinations |
Nizar Abo-Helo, Emad Muhammad, Sondus Ghaben-Amara, Shai Cohen |
89 |
[GO] |
2022―Apr―05 |
One year later: What Have We Learned About the Allergenicity and Adverse Reactions Associated with the SARS-CoV-2 vaccines |
Ana M Copaescu, Jaime S Rosa Duque, Elizabeth J. Phillips |
90 |
[GO] |
2022―Mrz―26 |
The impact of dupilumab treatment on SARS-CoV-2/COVID-19 antibody responses in atopic dermatitis patients |
Benjamin Ungar, Leore Lavin, Alexandra K. Golant, Alyssa Gontzes, Eden David, Yeriel D. Estrada, et al. (+3) Giselle K. Singer, Ana B. Pavel, Emma Guttman-Yassky |
91 |
[GO] |
2022―Mrz―25 |
Asthma and COVID-19 related outcomes in hospitalized patients: A single center experience |
Amy Ludwig, Caryn Brehm, Christopher Fung, Shijing Jia, Jonathan P. Troost, Laura Leuenberger, et al. (+5) Rayan Kaakati, Catherine Tarantine, Ella Christoph, Michael W. Sjoding, Njira Lugogo |
92 |
[GO] |
2022―Mrz―12 |
COVID-19 Vaccine Administration in Patients with Reported Reactions to Polyethylene Glycol- and Polysorbate-Containing Therapeutics |
Iris M. Otani, Lulu R. Tsao, Monica Tang |
93 |
[GO] |
2022―Mrz―04 |
Social Well-Being Amongst Children With vs. Without Food Allergy Before and During COVID-19 |
Kaitlyn A. Merrill, Elissa M. Abrams, Elinor Simons, Jennifer Lisa Penner Protudjer |
94 |
[GO] |
2022―Mrz―04 |
Graded COVID-19 Vaccine Administration: A Safe Alternative to Vaccine Avoidance |
Mitchell M. Pitlick, Alexei Gonzalez-Estrada, Miguel A. Park |
95 |
[GO] |
2022―Mrz―04 |
SARS-CoV-2 vaccines are well tolerated in patients with mastocytosis |
Gülseren Tuncay, Ozge Can Bostan, Ebru Damadoglu, Gül Karakaya, Ali Fuat Kalyoncu |
96 |
[GO] |
2022―Feb―25 |
Medication Adherence in Medicare Enrolled Older Adults with Asthma Before and During the COVID-19 Pandemic |
Olivia L. Ramey, Armando Silva Almodóvar, Milap C. Nahata |
97 |
[GO] |
2022―Feb―25 |
Effects of COVID-19 Pandemic on Children, Adolescents and Young Adults with Asthma in Rhode Island: Patterns in Emergency Department Utilization with Geospatial Mapping |
Daphne Koinis-Mitchell, Christina D'Angelo, Shira Dunsiger, Elizabeth McQuaid, Michelle L. Rogers |
98 |
[GO] |
2022―Feb―25 |
Ultra-rush immunotherapy with polymerized extracts during COVID-19 pandemic: safety of restarting administrations without dose-adjustments |
Mariana Bragança, José Luís Plácido, Luís Amaral |
99 |
[GO] |
2022―Feb―22 |
Coronavirus disease 2019 messenger RNA vaccine skin tests and serum histamine levels in allergic reactions |
Anita Kohli-Pamnani, Kristen Zapata, Tiffany Gibson, Pamela L. Kwittken |
100 |
[GO] |
2022―Feb―22 |
Immune parameters during anaphylaxis to messenger RNA coronavirus disease 2019 vaccines |
Luc de Chaisemartin, Antoine Diep, Cécile Gonnin, Angèle Soria, Annick Barbaud, Pascale Nicaise-Roland |
101 |
[GO] |
2022―Feb―12 |
A COVID-19 Vaccinated Patient with Phosphoinositide 3-Kinase Disease with Mild Illness Following SARS-CoV-2 Infection |
Sandeep Sarkaria, Amanpreet Kalkat, Robert Hostoffer |
102 |
[GO] |
2022―Feb―04 |
A Pediatric Asthma Camp Experience during the COVID-19 Pandemic |
Victoria Eng, Gary Paul Moreno, Jinny Chang, Myron Liebhaber |
103 |
[GO] |
2022―Jan―31 |
The Effect of COVID-19 on Asthma Visits |
Sean Stout, Helen Murphy, Aarti Pandya, Hung-Wen Yeh, Jay Portnoy |
104 |
[GO] |
2021―Dez―29 |
Psychological Impacts of COVID-19 on people with Asthma, Allergic Rhinitis and Food Allergy |
Alyssa G. Burrows, Anne K. Ellis |
105 |
[GO] |
2021―Dez―16 |
Impact of COVID-19 pandemic on frequency and severity of asthma exacerbations in an inner-city population |
Stefanie Zaner Fischell, Jonathan M. Fischell, Gloribel Olexa, Charles Callahan, Mary E. Bollinger |
106 |
[GO] |
2021―Nov―23 |
Messenger RNA vaccines and neutralizing anti-severe acute respiratory syndrome coronavirus 2 antibodies in patients with immunodeficiency |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
107 |
[GO] |
2021―Nov―20 |
Delayed hypersensitivity to the Comirnaty COVID-19 vaccine presenting with pneumonitis and rash |
Dr Alex Stoyanov, Dr Graeme Thompson, Dr Monique Lee, Professor Connie Katelaris |
108 |
[GO] |
2021―Nov―16 |
Utility and Futility of Skin Testing to Address Concerns Surrounding mRNA COVID-19 Vaccine Reactions |
Mitchell M Pitlick, Andrea N Sitek, Michael E D'Netto, Kelley N Dages, Sergio E Chiarella, Alexei Gonzalez-Estrada, et al. (+2) Avni Y Joshi, Miguel A Park |
109 |
[GO] |
2021―Nov―04 |
D020 ROLE OF CELLULAR CASPASES AND THERAPEUTIC POTENTIAL OF A PAN-CASPASE INHIBITOR, EMRICASAN, IN COVID-19. |
O. Alpan, R. Gupta, M. Latterich, M. Hubka, Z. Bukhari, L. Ndhlovu |
110 |
[GO] |
2021―Nov―04 |
M127 A MULTIFACETED APPROACH TO DIAGNOSIS AND MANAGEMENT OF POST COVID-19 ASSOCIATED DYSPNEA IN ADOLESCENTS |
M. Nevid, C. Lomas, N. Rabinovitch |
111 |
[GO] |
2021―Nov―04 |
A044 COVID-19 IN CVID: A LARGE HOSPITAL EXPERIENCE |
J. Greenmyer, A. Joshi |
112 |
[GO] |
2021―Nov―04 |
P155 ASSOCIATION OF PRIOR COVID-19 INFECTION AND SYSTEMIC SIDE EFFECTS AFTER COVID-19 VACCINATION IN HEALTHCARE POPULATION |
V. Phomakay, J. Lieberman |
113 |
[GO] |
2021―Nov―04 |
P003 DIAGNOSTIC UTILITY OF PEG/POLYSORBATE 80 SKIN TESTING AND ORAL CHALLENGE FOR COVID-19 MRNA VACCINE ALLERGY |
J. Ohtola, D. Lang, L. Pien |
114 |
[GO] |
2021―Nov―04 |
P191 DERMATITIS RELATED TO PPE UTILIZATION AMONG HEALTHCARE WORKERS DURING THE COVID-19 PANDEMIC |
D. Frankel, S. Mawhirt, M. Akerman, L. Fonacier |
115 |
[GO] |
2021―Nov―04 |
P173 IMPROVING ACCESS TO HEALTHCARE THROUGH TELEMEDICINE IN AN UNDERSERVED ASTHMA POPULATION DURING THE COVID-19 PANDEMIC |
A. Heffes-Doon, U. Kothari, A. Webb |
116 |
[GO] |
2021―Nov―04 |
P001 ALLERGISTS LEAD ANAPHYLAXIS PREPAREDNESS VIRTUAL WORKSHOPS FOR EARLY CHILDHOOD PROFESSIONALS AMIDST THE COVID-19 PANDEMIC |
M. Duggins, R. Shah, M. Baker, M. Marget, M. Oxford, A. Hoyt |
117 |
[GO] |
2021―Nov―04 |
A005 PATCH TESTING RESULTS IN ADULT PATIENTS WITH DERMATITIS DURING THE COVID-19 PANDEMIC |
S. Kong, S. Mawhirt, S. Islam |
118 |
[GO] |
2021―Nov―04 |
P091 BIOMARKERS OF INFLAMMATION AND IMMUNE REGULATION IN COVID-19 PATIENTS AND COVID 19 VACCINATED INDIVIDUALS |
M. Trusevich, L. Titov, T. Amvrosieva, I. Belskaya, L. DuBuske |
119 |
[GO] |
2021―Nov―04 |
P154 TREATING COVID-19 PNEUMONIA WITH DOXYCYCLINE DOES NOT IMPROVE MORTALITY |
M. Majzoub, R. Joks |
120 |
[GO] |
2021―Nov―04 |
M102 A CASE OF DELAYED UVULAR ANGIOEDEMA AFTER ADMINISTRATION OF THE COVID-19 VACCINE |
S. Kim, N. Mambetsariev, L. Grammer |
121 |
[GO] |
2021―Nov―04 |
M044 POLYETHYLENE GLYCOL ALLERGY TESTING AN ADOLESCENT WITH ANAPHYLAXIS TO PEG-ASPARAGINASE BEFORE ADMINISTERING PFIZER-BIONTECH COVID-19 VACCINE |
M. Breidenbaugh |
122 |
[GO] |
2021―Nov―04 |
P006 POLYETHYLENE GLYCOL ALLERGY LABEL: NOT AN ABSOLUTE CONTRAINDICATION TO RECEIVING AN MRNA COVID-19 VACCINE |
M. Pitlick, K. Dages, A. Joshi, M. Park |
123 |
[GO] |
2021―Nov―04 |
A001 MRNA COVID-19 VACCINE ADVERSE EVENTS FOLLOWING IMMUNIZATION: SHOULD YOU RECOMMEND THE SECOND DOSE? |
B. St. Clair, D. Hoffman, R. Lee, J. Montgomery |
124 |
[GO] |
2021―Nov―04 |
P177 COVID-19 VACCINE ADVERSE REACTIONS IN HOSPITAL EMPLOYEES |
H. Jin, M. Ackerman, M. Phillips, C. Cohan, S. Salvati, M. Wilkenfeld, L. Fonacier |
125 |
[GO] |
2021―Nov―04 |
M260 EVALUATION OF THE HYPERSENSITIVITY RISK OF THE COVID-19 VACCINE COMPONENTS: A SERIES OF CASE REPORTS |
T. Delgado Guzmán, S. Gonzalez-Diaz, R. Villarreal Gonzalez, C. De Lira-Quezada, A. Chávez Ruiz, C. Macouzet-Sanchez |
126 |
[GO] |
2021―Nov―04 |
M098 A CASE OF HEREDITARY A-TRYPTASEMIA EXACERBATION FOLLOWING SECOND DOSE OF MRNA COVID-19 VACCINE ON OMALIZUMAB |
J. Li, R. Saff |
127 |
[GO] |
2021―Nov―04 |
M275 COVID-19 VACCINE RELATED URTICARIAL VASCULITIS |
S. Bhatti, J. McCracken |
128 |
[GO] |
2021―Nov―04 |
M015 A PATIENT WITH AN ALLERGIC REACTION TO THE PFIZER COVID-19 VACCINE SUBSEQUENTLY TOLERATES JOHNSON&JOHNSON VACCINATION |
A. Patterson, Z. Ren, M. Jerath |
129 |
[GO] |
2021―Nov―04 |
M019 COVID-19 VACCINE-ASSOCIATED ANAPHYLAXIS: BASOPHIL ACTIVATION IN A SPECIFIC IGE AND IGG NEGATIVE PATIENT |
S. Jiang, E. Smith, V. Vo, V. Sampath, T. Snow, M. Shah, et al. (+3) A. Heider, C. Akdis, K. Nadeau |
130 |
[GO] |
2021―Nov―04 |
M004 UNUSUAL ANAPHYLACTIC REACTION TO COVID-19 VACCINE-CONSTRUCTING A HISTORY WITH TECHNOLOGY AS AN AID |
E. Montgomery, D. Sheth |
131 |
[GO] |
2021―Nov―04 |
P095 LEVELS OF IGG TO SARS-COV-2 IN RECIPIENTS OF COVID-19 VACCINES: LONGITUDINAL MONITORING WITH QUANTITATIVE ASSAY |
J. Patel, B. Keshavarz, N. Richards, L. Workman, L. Muehling, D. Murphy, et al. (+4) W. Eschenbacher, M. Nelson, T. Platts-Mills, J. Wilson |
132 |
[GO] |
2021―Nov―04 |
P094 IMMUNOLOGIC EFFICACY OF POOLED MESENCHYMAL STEM CELLS IN PATIENTS WITH SEVERE COVID-19-ASSOCIATED PNEUMONIA |
A. Rynda, A. Hancharou, N. Antonevich, S. Aliakseichyk, Y. Pankratova, V. Isachkin, L. DuBuske |
133 |
[GO] |
2021―Nov―04 |
P096 LIPOPOLYSACCHARIDE-BINDING SYSTEMS IN PATIENTS WITH SARS-COV-19 INFECTION HAVING VARIOUS DEGREES OF SEVERITY |
V. Beloglazov, I. Yatskov, A. Nikolaeva, E. Lavrenchuk, L. DuBuske |
134 |
[GO] |
2021―Nov―04 |
A041 DETECTION OF SARS-COV-2 ANTIBODIES IN IMMUNOGLOBULIN PRODUCTS |
K. Cousins, K. Sano, G. Singh, N. Aboelregal, S. Jeong, H. Ho, et al. (+2) F. Krammer, C. Cunningham-Rundles |
135 |
[GO] |
2021―Nov―04 |
A045 INADEQUATE SARS-COV-2 ANTIBODY RESPONSE TO MRNA SARS-COV-2 VACCINE IN ADOLESCENT KIDNEY TRANSPLANT RECIPIENTS |
L. Loop, C. Crane, C. Anterasian, B. Geng, E. Ingulli |
136 |
[GO] |
2021―Nov―04 |
M013 SUCCESSFUL FOUR-STEP GRADED-DOSE ADMINISTRATION TO THE PFIZER-MRNA SARS-COV-2 VACCINE IN A PATIENT WITH PREVIOUS ANAPHYLAXIS |
D. Morgenstern-Kaplan, I. Carrillo-Martin, C. Rivera, M. Parkulo, A. Gonzalez-Estrada |
137 |
[GO] |
2021―Nov―04 |
M010 DIAGNOSTIC CHALLENGE IN EVALUATING THE RISK AND MANAGEMENT OF ALLERGIC REACTION(S) TO SARS-COV-2 VACCINES |
E. Abou-Jaoude, T. Nsouli, N. Diliberto, S. Nsouli, J. Bellanti |
138 |
[GO] |
2021―Nov―04 |
M191 IMMUNE ASSESSMENT IN POST-ACUTE SEQUALA OF SARS-COV2 INFECTION (PASC): EVIDENCE OF PERSISTENT IMMUNE ACTIVATION? |
V. Ahluwalia, V. Iyer, A. Joshi |
139 |
[GO] |
2021―Okt―28 |
Atopic comorbidity has no impact on severity and course of COVID-19 disease in adult patients |
Julia Zarnowski, Paula Kage, Jan-Christoph Simon, Regina Treudler |
140 |
[GO] |
2021―Okt―25 |
The COVID-19 Pandemic: Adverse Effects on the Social Determinants of Health in Children and Families |
Elissa M Abrams, Matthew Greenhawt, Marcus Shaker, Andrew D Pinto, Ian Sinha, Alexander Singer |
141 |
[GO] |
2021―Okt―25 |
Allergic reactions to COVID-19 vaccines and addressing vaccine hesitancy: Northwell Health experience |
Blanka Kaplan, Sherry Farzan, Gina Coscia, David W. Rosenthal, Alissa McInerney, Artemio M. Jongco, et al. (+2) Punita Ponda, Vincent R. Bonagura |
142 |
[GO] |
2021―Okt―25 |
Delayed angioedema following SARS-CoV-2 mRNA vaccine administration |
Melissa M. Watts, Laura E. Maurer, Leslie C. Grammer, Carol A. Saltoun, Whitney W. Stevens |
143 |
[GO] |
2021―Okt―19 |
Asthma in older adults with severe COVID-19: clinical outcomes and predictors of mortality. |
Sergey N. Avdeev, Anna A. Pozdnakova, Viliya V. Gaynitdinova, Svetlana Yu Chikina, Anna E. Vlasenko |
144 |
[GO] |
2021―Okt―13 |
Trends in racial disparities in asthma emergency department utilization during COVID-19 |
Rubayet Hossain, Fang Zhao, Marie Michenkova, David Kaelber, Yasir Tarabichi |
145 |
[GO] |
2021―Okt―13 |
Polyethylene glycol and polysorbate testing in twelve patients prior to or after COVID-19 vaccine administration |
Taya Carpenter, Justin Konig, Jillian Hochfelder, Subhadra Siegel, Melissa Gans |
146 |
[GO] |
2021―Sep―30 |
Evaluation of Anaphylaxis Risk by Skin Testing with Covid-19 mRNA Vaccines on Anaphylactic Patients |
Marek M. Pienkowski, Stefan M. Pienkowski |
147 |
[GO] |
2021―Sep―27 |
National decline in asthma exacerbations in US during COVID19 pandemic |
Regina W Lam, Jonathan W Inselman, Molly M Jeffery, Jacob T Maddux, Matthew A Rank |
148 |
[GO] |
2021―Sep―20 |
Non-IgE mediated allergy associated with Pfizer-BioNTech COVID-19 vaccine excipient polyethylene glycol |
Shirley Y. Jiang, Eric M. Smith, Victor Vo, Cezmi Akdis, Kari C. Nadeau |
149 |
[GO] |
2021―Sep―03 |
COVID-19 Vaccine Hypersensitivity Evaluated with Vaccine and Excipients Allergy Skin Testing |
Anita Kohli-Pamnani, Kristen Zapata, Tiffany Gibson, Pamela L. Kwittken |
150 |
[GO] |
2021―Aug―01 |
Eosinophilic inflammation, coronavirus disease 2019, and asthma |
Sanjay Ramakrishnan, Mona Bafadhel |
151 |
[GO] |
2021―Jul―31 |
Specific antibody response of common variable immunodeficiency patients to BNT162b2 COVID-19 vaccination |
Nizar Abo-helo, Emad Muhammad, Sondus Ghaben-amara, Josef Panasoff, Shai Cohen |
152 |
[GO] |
2021―Jul―31 |
Biphasic anaphylaxis after first dose of mRNA COVID-19 vaccine with positive polysorbate 80 skin testing |
Mitchell M Pitlick, Miguel A Park, Alexei Gonzalez-Estrada, Sergio E Chiarella |
153 |
[GO] |
2021―Jul―11 |
Anaphylaxis-related knowledge and concerns in Canadian families during COVID-19 |
Sofianne Gabrielli, Jennifer LP Protudjer, Gregory Gooding, Jennifer Gerdts, Moshe Ben-Shoshan |
154 |
[GO] |
2021―Jun―20 |
Telemedicine During the COVID-19 Pandemic for Pediatric Eosinophilic Esophagitis Patients |
Anupama Kewalramani, Jaylyn Waddell, Elaine Leonard Puppa |
155 |
[GO] |
2021―Jun―18 |
Eosinophils in antiviral immunity and (perhaps) a benefit of having asthma during the SARS-CoV2 pandemic |
Ryan Eid, Larry Borish |
156 |
[GO] |
2021―Mai―19 |
Seroconversion Following COVID-19 Vaccination in Immune Deficient Patients |
Jacqueline Squire, Dr. Avni Joshi |
157 |
[GO] |
2021―Mai―18 |
Skin Prick Test Practice In Allergy Clinics During Covid-19 Pandemic |
Resat Kendirlinan, Pamir Cerci, Dilsad Mungan |
158 |
[GO] |
2021―Mai―16 |
Home epinephrine-treated reactions in food allergy oral immunotherapy: Lessons from COVID-19 lockdown |
Liat Nachshon, Michael R Goldberg, Michael B Levy, Naama Epstein-Rigbi, Yael Koren, Arnon Elizur |
159 |
[GO] |
2021―Mai―08 |
Commentary on Eosinophilic inflammation, COVID-19, and asthma - are inhaled corticosteroids the missing link? |
Kam Sing Ho, Daniel Howell, Linda Rogers, Bharat Narasimhan, Hannah Verma, David Steiger |
160 |
[GO] |
2021―Mai―07 |
Investigating Air Pollution as a Contributor to Health Disparities During the COVID-19 Pandemic |
Harleen Marwah, Natalie Rosseau, Sowmya Mangipudi, Caitlin Ward, Anjeni Keswani |
161 |
[GO] |
2021―Mai―05 |
Risk of allergic reaction in patients with atopic disease and recent COVID-19 vaccination |
Kelley N. Dages, Mitchell M. Pitlick, Avni Y. Joshi, Miguel A. Park |
162 |
[GO] |
2021―Mai―01 |
The evidence is in that asthma is not associated with severe coronavirus disease 2019 |
Dylan T. Timberlake, Mitchell H. Grayson |
163 |
[GO] |
2021―Apr―08 |
Disproportionality Analysis of Anaphylactic Reactions after Vaccination with mRNA COVID-19 Vaccines in the United States |
Guillermo Rodriguez-Nava, Goar Egoryan, Daniela Patricia Trelles-Garcia, Maria Adriana Yanez-Bello, Ricardo Murguia-Fuentes |
164 |
[GO] |
2021―Mrz―27 |
Drug Desensitization in the Covid-19 Pandemic Era: Local Success to Widespread Potential |
Kimberly G. Blumenthal, Mariana Castells, Aleena Banerji |
165 |
[GO] |
2021―Mrz―27 |
Misdiagnosis of systemic allergic reactions to mRNA COVID-19 vaccines |
John M Kelso |
166 |
[GO] |
2021―Mrz―26 |
Evaluating the impact of COVID-19 on asthma morbidity: a comprehensive analysis of potential influencing factors |
Olga L Guijon, Tricia Morphew, Morphew Consulting, Louis Ehwerhemuepha, Stanley P Galant |
167 |
[GO] |
2021―Mrz―26 |
Polyethylene Glycol and Polysorbate Skin Testing in the Evaluation of COVID-19 Vaccine Reactions: Early Report |
Mitchell M Pitlick, Andrea N Sitek, Susan A Kinate, Avni Y Joshi, Miguel A Park |
168 |
[GO] |
2021―Mrz―26 |
Prepping for a pandemic |
Kelsey Lecerf, Mitchell H. Grayson |
169 |
[GO] |
2021―Feb―27 |
The Relationship Between Asthma, Eosinophilia, and Outcomes in COVID-19 Infection |
Kam Sing Ho, Daniel Howell, Linda Rogers, Bharat Narasimhan, Hannah Verma, David Steiger |
170 |
[GO] |
2021―Feb―25 |
Asthma in COVID-19 suspected and diagnosed patients |
Lijuan Cao, Sandra Lee, James G. Krings, Adriana M. Rauseo, Daniel Reynolds, Rachel Presti, et al. (+4) Charles Goss, Philip A. Mudd, Jane A. O'Halloran, Leyao Wang |
171 |
[GO] |
2021―Feb―19 |
Asthma in patients with coronavirus disease 2019: a systematic review and meta-analysis |
Li Shi, Jie Xu, Wenwei Xiao, Ying Wang, Yuefei Jin, Shuaiyin Chen, et al. (+3) Guangcai Duan, Haiyan Yang, Yadong Wang |
172 |
[GO] |
2021―Jan―23 |
Asthma and allergic diseases are not risk factors for hospitalization in children with COVID-19 |
Burcin Beken, Gokcen Kartal Ozturk, Fatma Deniz Aygun, Cigdem Aydogmus, Himmet Haluk Akar |
173 |
[GO] |
2021―Jan―23 |
Effect of Patient and Parental Anxiety on Adherence to Subcutaneous Allergen Immunotherapy During COVID-19 Pandemic |
Ilknur Kulhas Celik, Azize Pinar Metbulut, Ozden Sukran Uneri, Gulser Senses Dinc, Emine Dibek Misirlioglu |
174 |
[GO] |
2021―Jan―23 |
Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines: Allergic Reactions to mRNA SARS-CoV-2 Vaccines |
Kevin R. Murphy, Niraj C. Patel, Daniel Ein, Mary Hudelson, Sangeetha Kodoth, Gailen D. Marshall, et al. (+2) Purvi Parikh, Michael S. Blaiss |
175 |
[GO] |
2021―Jan―14 |
SARS-CoV2 infection in those on Mepolizumab therapy |
Adnan Azim, Laura Pini, Zeeshan Khakwani, Santosh Kumar, Peter Howarth |
176 |
[GO] |
2020―Dez―30 |
Monitoring Neutrophil to Lymphocyte Ratio in COVID-19 Patients Receiving Tocilizumab |
Nicholas L. Hartog, Alan T. Davis, Jeremy W. Prokop, Andrew Walls, Surender Rajasekaran |
177 |
[GO] |
2020―Dez―11 |
Zoonotic coronavirus epidemics: SARS, MERS, and COVID-19 |
Monica Fung, Iris Otani, Michele Pham, Jennifer Babik |
178 |
[GO] |
2020―Nov―22 |
Non-neutralizing antibodies and limitations of serological testing for SARS-CoV-2 in patients receiving replacement immunoglobulin products |
Deepti Vellaichamy Manian, Chelsee Jensen, Elitza S. Theel, John R. Mills, Avni Joshi |
179 |
[GO] |
2020―Nov―13 |
P350 EFFECTS OF ATOPIC DISEASE ON DISEASE SEVERITY IN COVID-19 |
D. Timberlake, D. Narayanan, P. Ogbogu, R. Raveendran, B. Prince, R. Scherzer, et al. (+2) K. Porter, M. Grayson |
180 |
[GO] |
2020―Nov―13 |
M030 RITUXIMAB-INDUCED SERUM SICKNESS IN A PEDIATRIC PATIENT WITH MULTIPLE AUTOIMMUNE DISEASES AND HISTORY OF COVID-19 |
K. Nguyen, A. Kazatsky |
181 |
[GO] |
2020―Nov―13 |
M412 A BALANCING ACT: TREATMENT OF COVID-19 AND CYTOMEGALOVIRUS IN A PATIENT WITH PRIMARY IMMUNODEFICIENCY |
V. Szafron, M. Pereira, T. Vogel, D. Leung, L. Forbes-Satter |
182 |
[GO] |
2020―Nov―13 |
A050 THE IMPACT OF COVID-19 AND DISEASE CONTROL MEASURES ON PEDIATRIC FOOD ALLERGY PARENTS/CAREGIVERS AND PATIENTS |
C. Warren, S. Chinthrajah, P. Newmark, L. Herbert, S. Fox, K. Nadeau, et al. (+4) H. Sharma, A. Assa'ad, M. Tobin, R. Gupta |
183 |
[GO] |
2020―Nov―13 |
M405 COVID-19 ASSOCIATED EOSINOPHILIC LICHEN PLANUS |
G. Hudes, M. Weingarten, D. Sanchez Tejera |
184 |
[GO] |
2020―Nov―13 |
M402 FACIAL CONTACT DERMATITIS DUE TO MASKS IN THE COVID-19 ERA |
Y. Dhamija, N. Khan, K. Schmidlin |
185 |
[GO] |
2020―Nov―13 |
M413 COVID-19 IN A PATIENT WITH CVID AND CONTRAINDICATIONS TO SEVERAL POTENTIAL TREATMENTS |
E. Ender, P. Timothy |
186 |
[GO] |
2020―Nov―13 |
M403 COVID-19 IN A PATIENT WITH HYPER-EOSINOPHILIC SYNDROME TREATED WITH MEPOLIZUMAB |
Z. Khakwani, S. Kumar |
187 |
[GO] |
2020―Nov―13 |
M410 COVID-19 INFECTION IN A PATIENT WITH SECONDARY HYPOGAMMAGLOBULINEMIA |
D. Maghen, G. Lutz, A. Schneider |
188 |
[GO] |
2020―Nov―13 |
M406 SELF-LIMITED COVID-19 INFECTION IN ARTEMIS HYPOMORPHIC SCID: ARE B CELLS DISPENSABLE? |
S. Gabryszewski, D. Sun, S. Jyonouchi, K. Sullivan, S. Henrickson |
189 |
[GO] |
2020―Nov―13 |
M400 MANAGING A CASE OF REPORTED LOCAL LIDOCAINE ALLERGY IN A PREGNANT WOMAN DURING COVID-19 PANDEMIC |
H. Jin, O. Waqar, R. Miller |
190 |
[GO] |
2020―Nov―13 |
M409 ELECTRONIC CIGARETTE OR VAPING PRODUCT USE-ASSOCIATED LUNG INJURY AMIDST THE COVID-19 PANDEMIC |
A. Diaz, S. Sani, S. Mawhirt |
191 |
[GO] |
2020―Nov―13 |
P201 PERCEIVED APATHY FROM PHYSICIANS ASSOCIATED WITH EMOTIONAL DISTRESS AMID COVID-19 PANDEMIC IN ADULTS WITH ASTHMA |
S. Alonzi, T. Coaston, M. Silverstein |
192 |
[GO] |
2020―Nov―13 |
M414 LOMATIUM DISSECTUM RASH: A COMPLICATION OF COVID-19 PROPHYLAXIS THERAPY |
J. Nelson |
193 |
[GO] |
2020―Nov―13 |
M408 AN UNUSUAL MISSED DIAGNOSIS OF MULTIFACETED CLINICAL CASE OF CORONAVIRUS DISEASE 2019 MIMICKING UNCONTROLLED ASTHMA |
S. Nsouli |
194 |
[GO] |
2020―Nov―13 |
M407 COMPLICATIONS OF CORONAVIRUS IN A PATIENT WITH CVID |
D. Urschel, M. Cardenas-Morales, V. Hernandez-Trujillo |
195 |
[GO] |
2020―Nov―13 |
M411 ACTIVE TUBERCULOSIS (TB) MASQUERADING AS AN ASTHMA EXACERBATION DURING A SARS-COV-2 (COVID 19) PANDEMIC |
G. Hudes, M. Beronilla |
196 |
[GO] |
2020―Nov―13 |
M404 PERSISTENT POSITIVITY OF SARS-COV-2 NASOPHARYNGEAL PCR TEST IN A CHILD WITH ASTHMA |
M. Pitlick, A. Joshi |
197 |
[GO] |
2020―Nov―13 |
A060 INNER CITY ASTHMA TELE-MEDICINE DURING COVID PANDEMIC |
K. Kwong |
198 |
[GO] |
2020―Nov―06 |
Potential Association of Mast Cells with COVID-19 |
Theoharis C. Theoharides |
199 |
[GO] |
2020―Nov―05 |
Controlled Trials Needed to Prove Efficacy and Safety of Convalescent Plasma Therapy in COVID-19 |
Nicholas Hartog, Amanda Holsworth, Surender Rajasekaran |
200 |
[GO] |
2020―Okt―12 |
Asthma is associated with increased risk of intubation but not hospitalization or death in coronavirus disease 2019 |
Jamie A. Rosenthal, Seemal F. Awan, Jonathan Fintzi, Anjeni Keswani, Daniel Ein |
201 |
[GO] |
2020―Sep―18 |
High anxiety and health-related quality-of-life in families with children with food allergy during COVID-19 |
J.L.P. Protudjer, M. Golding, M.R. Salisbury, E.M. Abrams, L.E. Roos |
202 |
[GO] |
2020―Sep―07 |
Differentiating characteristics of asthmatic patients in the SARS-CoV2 infection. |
José Lemus Calderón, Pedro Beneyto Martin, Raúl Guzmán Rodriguez, Horacio Caligaris Cataldi, Carlos Senent Sánchez |
203 |
[GO] |
2020―Aug―25 |
U.S. Public Health Resources for COVID-19 That Are Relevant to Allergy/Immunology |
Joy Hsu |
204 |
[GO] |
2020―Aug―25 |
Children and adolescents with allergy and/or asthma seem to be protected from coronavirus disease 2019 |
Giorgio Ciprandi, Amelia Licari, Gaetana Filippelli, Maria Angela Tosca, Gian Luigi Marseglia |
205 |
[GO] |
2020―Aug―18 |
A fatal case of COVID-19 in a patient with common variable immunodeficiency |
Jyotsna Mullur, Alberta Wang, Anna Feldweg |
206 |
[GO] |
2020―Aug―17 |
Perceived stress links income loss and urticaria activity during the COVID-19 pandemic |
Minxue Shen, Yangjian Xiao, Yan Yuan, Xiang Chen, Jie Li |
207 |
[GO] |
2020―Aug―01 |
Anaphylactic shock following diagnosis of COVID-19 |
Alberto Alvarez-Perea, María Luisa Baeza |
208 |
[GO] |
2020―Aug―01 |
Clinical course and outcomes in patients with asthma hospitalized for SARS-CoV-2 pneumonia:a single-center, retrospective study. |
Carlo Lombardi, Elena Roca, Barbara Bigni, Marcello Cottini, Giovanni Passalacqua |
209 |
[GO] |
2020―Jul―24 |
Smell loss is a prognostic factor for lower severity of COVID-19 |
Katharine J. Foster, Emilio Jauregui, Bobby Tajudeen, Faraz Bishehsari, Mahboobeh Mahdavinia |
210 |
[GO] |
2020―Jul―22 |
COVID-19 - associated urticaria with angioedema in a morbidly obese male successfully treated with glucocorticoids |
Richard F. Lockey, Stephanie N. Hudey |
211 |
[GO] |
2020―Jul―18 |
Atopy is predictive of a decreased need for hospitalization for COVID-19 |
Anjeni Keswani, Klodian Dhana, Jamie A. Rosenthal, Donyea Moore, Mahboobeh Mahdavinia |
212 |
[GO] |
2020―Jul―01 |
Idiopathic Nonhistaminergic Acquired Angioedema in a Patient with COVID-19 |
Veronica Azmy, Jemma Benson, Keith Love, Ryan Steele |
213 |
[GO] |
2020―Jul―01 |
Use of inhaled corticosteroids in asthma and coronavirus disease 2019 |
Brian Lipworth, Rory Chan, Chris RuiWen Kuo |
214 |
[GO] |
2020―Jun―22 |
Patient Satisfaction with Telemedicine Encounters in an Allergy/Immunology Practice During the COVID-19 Pandemic |
S. Shahzad Mustafa, Luanna Yang, Mahta Mortezavi, Karthik Vadamalai, Allison Ramsey |
215 |
[GO] |
2020―Jun―14 |
COVID-19, SEVERE ASTHMA AND BIOLOGICS |
Ismael García-Moguel, Rocío Díaz Campos, Sergio Alonso Charterina, Consuelo Fernández Rodríguez, Jesús Fernández Crespo |
216 |
[GO] |
2020―Jun―10 |
COVID-19 and allergen immunotherapy: theoretical benefits invite to adjustments in practice recommendations |
Désirée Larenas-Linnemann, Noel Rodríguez-Pérez, Jose Antonio Ortega-Martell, Virginia Blandon Vijil, Jorge A. Luna-Pech |
217 |
[GO] |
2020―Jun―04 |
Positive Outcome in a COVID-19 patient with Common Variable Immunodeficiency after IVIG |
Rana Aljaberi, Kholoud Wishah |
218 |
[GO] |
2020―Mai―27 |
Rethinking Respiratory Function Test Lab in the Era of COVID-19 : considerations about the “today” and the “day after” |
Lombardi Carlo, Milanese Manlio, Cottini Marcello |
219 |
[GO] |
2020―Mai―22 |
Drug allergy labeling and delabeling in the coronavirus disease 2019 era |
Mariana C. Castells |
220 |
[GO] |
2020―Mai―11 |
Clinical course of asthma in 4 cases of COVID-19 infection |
Christopher D. Codispoti, Sindhura Bandi, Payal Patel, Mahboobeh Mahdavinia |
221 |
[GO] |
2020―Mai―06 |
Dietary Management of Food Protein-Induced Enterocolitis Syndrome during COVID-19 Pandemic |
Marion Groetch, Raquel Durban, Rosan Meyer, Carina Venter, Anna Nowak-Wegrzyn |
222 |
[GO] |
2020―Mai―06 |
Asthma, biologics, corticosteroids, and coronavirus disease 2019 |
Ayobami T. Akenroye, Robert Wood, Corinne Keet |
223 |
[GO] |
2020―Mai―05 |
The Clinical Observation of a CVID Patient Infected with COVID-19 |
Lauren Fill, Lauren Hadney, Kelsey Graven, Roberta Persaud, Robert Hostoffer |
224 |
[GO] |
2020―Mai―05 |
Managing FPIES during the COVID-19 pandemic-expert recommendations |
A. Nowak-Wegrzyn, A. Cianferoni, J.A. Bird, A. Fiocchi, J.C. Caubet, Stefania Arasi, et al. (+12) Ashis V. Barad, Theresa Bingemann, Terri Brown-Whitehorn, Raquel Durban, Todd Green, George Konstantinou, Stephanie Leonard, Jennifer Lightdale, Antonella Muraro, Ichiro Nomura, Jonathan Spergel, Carina Venter |